Suppr超能文献

一种与脑蛋白激酶II调节亚基共纯化的钙调蛋白结合蛋白的鉴定。

Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II.

作者信息

Sarkar D, Erlichman J, Rubin C S

出版信息

J Biol Chem. 1984 Aug 10;259(15):9840-6.

PMID:6086653
Abstract

Highly purified preparations of cytosolic brain RII contain a tightly associated polypeptide with a Mr of 75,000 (P75). When purified brain and heart RII were preincubated with Ca2+ and 125I-calmodulin and then were subjected to polyacrylamide gel gelectrophoresis under nondenaturing conditions a major calmodulin-binding component was found only in the brain RII sample. The calmodulin-binding activity exhibited a higher sedimentation coefficient (9 S) than free RII (5 S) indicating that it might be a complex of P75 and RII dimers. This possibility was investigated using two specific monoclonal antibodies. Western blot analyses revealed that monoclonal antibody 918 exclusively bound to P75 in the brain RII preparation while monoclonal antibody 107 complexed RII. The calmodulin-binding component was noncovalently labeled with 125I-calmodulin and separated from excess free RII by polyacrylamide gel electrophoresis under nondenaturing conditions. The identity of the polypeptides comprising the binding protein was subsequently established by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot analysis. Polypeptides with Mrs values of 55,000 and 75,000 that bound monoclonal antibodies 107 and 918, respectively, were observed. Thus the calmodulin-binding component in brain RII preparations is a complex containing an RII dimer and one or two molecules of P75. P75 was also present in high concentrations in Triton X-100 extracts prepared from cerebral cortex and liver membranes. P75 is phosphorylated by both cAMP-dependent and calcium-phospholipid-activated protein kinases.

摘要

高度纯化的脑胞质RII制剂含有一种紧密结合的多肽,其分子量为75,000(P75)。当纯化的脑和心脏RII与Ca2+和125I-钙调蛋白预孵育,然后在非变性条件下进行聚丙烯酰胺凝胶电泳时,仅在脑RII样品中发现一个主要的钙调蛋白结合成分。该钙调蛋白结合活性表现出比游离RII(5S)更高的沉降系数(9S),表明它可能是P75和RII二聚体的复合物。使用两种特异性单克隆抗体研究了这种可能性。蛋白质印迹分析显示,单克隆抗体918仅与脑RII制剂中的P75结合,而单克隆抗体107与RII形成复合物。钙调蛋白结合成分用125I-钙调蛋白进行非共价标记,并在非变性条件下通过聚丙烯酰胺凝胶电泳与过量的游离RII分离。随后通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和蛋白质印迹分析确定了构成结合蛋白的多肽的身份。观察到分子量分别为55,000和75,000的多肽,它们分别与单克隆抗体107和918结合。因此,脑RII制剂中的钙调蛋白结合成分是一种复合物,包含一个RII二聚体和一或两个P75分子。P75在从大脑皮层和肝膜制备的Triton X-100提取物中也以高浓度存在。P75可被cAMP依赖性蛋白激酶和钙-磷脂激活的蛋白激酶磷酸化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验